Research output per year
Research output per year
Fingerprint
Dive into the research topics where John Sarantopoulos is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A phase 2, multicenter, open-label study of anti-LAG-3 ieramilimab in combination with anti-PD-1 spartalizumab in patients with advanced solid malignancies
Lin, C. C., Garralda, E., Schöffski, P., Hong, D. S., Siu, L. L., Martin, M., Maur, M., Hui, R., Soo, R. A., Chiu, J., Zhang, T., Ma, B., Kyi, C., Tan, D. S. W., Cassier, P. A., Sarantopoulos, J., Weickhardt, A., Carvajal, R. D., Spratlin, J. & Esaki, T. & 10 others, , 2024, In: OncoImmunology. 13, 1, 2290787.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
Utilizing metformin to prevent metabolic syndrome due to androgen deprivation therapy (ADT): a randomized phase II study of metformin in non-diabetic men initiating ADT for advanced prostate cancer
Mahalingam, D., Hanni, S., Serritella, A. V., Fountzilas, C., Michalek, J., Hernandez, B., Sarantopoulos, J., Datta, P., Romero, O., Pillai, S. M. A., Kuhn, J., Pollak, M. & Thompson, I. M., 2023, In: Oncotarget. 14, 1, p. 622-636 15 p.Research output: Contribution to journal › Article › peer-review
Open Access -
A First-in-Human, Phase I, Multicenter, Open-Label, Dose-Escalation Study of PCA062: An Antibody-Drug Conjugate Targeting P-Cadherin, in Patients With Solid Tumors
Duca, M., Lim, D. W. T., Subbiah, V., Takahashi, S., Sarantopoulos, J., Varga, A., D'Alessio, J. A., Abrams, T., Sheng, Q., Tan, E. Y., Rosa, M. S., Gonzalez-Maffe, J., Sand-Dejmek, J., Fabre, C. & Martin, M., Apr 2022, In: Molecular cancer therapeutics. 21, 4, p. 625-634 10 p.Research output: Contribution to journal › Article › peer-review
6 Scopus citations -
Antitumor Activity of Lurbinectedin, a Selective Inhibitor of Oncogene Transcription, in Patients with Relapsed Ewing Sarcoma: Results of a Basket Phase II Study
Subbiah, V., Braña, I., Longhi, A., Boni, V., Delord, J. P., Awada, A., Boudou-Rouquette, P., Sarantopoulos, J., Shapiro, G. I., Elias, A., Ratan, R., Fernandez, C., Kahatt, C., Cullell-Young, M., Siguero, M., Zeaiter, A. & Chawla, S. P., Jul 1 2022, In: Clinical Cancer Research. 28, 13, p. 2762-2770 9 p.Research output: Contribution to journal › Article › peer-review
Open Access15 Scopus citations -
ARRY-382 in Combination with Pembrolizumab in Patients with Advanced Solid Tumors: Results from a Phase 1b/2 Study
Johnson, M., Dudek, A. Z., Sukari, A., Call, J., Kunk, P. R., Lewis, K., Gainor, J. F., Sarantopoulos, J., Lee, P., Golden, A., Harney, A., Rothenberg, S. M., Zhang, Y. & Goldman, J. W., Jun 15 2022, In: Clinical Cancer Research. 28, 12, p. 2517-2526 10 p.Research output: Contribution to journal › Article › peer-review
Open Access23 Scopus citations
Datasets
-
Phase 1 study of M2698, a p70S6K/AKT dual inhibitor, in patients with advanced cancer
Tsimberidou, A.-M. (Creator), Shaw, J. V. (Creator), Juric, D. (Creator), Verschraegen, C. (Creator), Weise, A. M. (Creator), Sarantopoulos, J. (Creator), Lopes, G. (Creator), Nemunaitis, J. (Creator), Mita, M. (Creator), Park, H. (Creator), Ellers-Lenz, B. (Creator), Tian, H. (Creator), Xiong, W. (Creator), Kaleta, R. (Creator) & Kurzrock, R. (Creator), Figshare, 2021
DOI: 10.6084/m9.figshare.c.5568537.v1, https://springernature.figshare.com/collections/Phase_1_study_of_M2698_a_p70S6K_AKT_dual_inhibitor_in_patients_with_advanced_cancer/5568537/1
Dataset
-
Pharmacokinetics of carfilzomib in patients with advanced malignancies and varying degrees of hepatic impairment: an open-label, single-arm, phase 1 study
Brown, J. (Creator), Plummer, R. (Creator), Bauer, T. M. (Creator), Anthony, S. (Creator), Sarantopoulos, J. (Creator), Vos, F. (Creator), White, M. (Creator), Schupp, M. (Creator), Ou, Y. (Creator) & Vaishampayan, U. (Contributor), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3895900.v1, https://figshare.com/collections/Pharmacokinetics_of_carfilzomib_in_patients_with_advanced_malignancies_and_varying_degrees_of_hepatic_impairment_an_open-label_single-arm_phase_1_study/3895900/1
Dataset
-
Phase 1 study of M2698, a p70S6K/AKT dual inhibitor, in patients with advanced cancer
Tsimberidou, A.-M. (Creator), Shaw, J. V. (Creator), Juric, D. (Creator), Verschraegen, C. (Creator), Weise, A. M. (Creator), Sarantopoulos, J. (Creator), Lopes, G. (Creator), Nemunaitis, J. (Creator), Mita, M. (Creator), Park, H. (Creator), Ellers-Lenz, B. (Creator), Tian, H. (Creator), Xiong, W. (Creator), Kaleta, R. (Creator) & Kurzrock, R. (Creator), Figshare, 2021
DOI: 10.6084/m9.figshare.c.5568537, https://springernature.figshare.com/collections/Phase_1_study_of_M2698_a_p70S6K_AKT_dual_inhibitor_in_patients_with_advanced_cancer/5568537
Dataset
-
Pharmacokinetics of carfilzomib in patients with advanced malignancies and varying degrees of hepatic impairment: an open-label, single-arm, phase 1 study
Brown, J. (Creator), Plummer, R. (Creator), Bauer, T. M. (Creator), Anthony, S. (Creator), Sarantopoulos, J. (Creator), Vos, F. (Creator), White, M. (Creator), Schupp, M. (Creator), Ou, Y. (Creator) & Vaishampayan, U. (Contributor), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3895900, https://figshare.com/collections/Pharmacokinetics_of_carfilzomib_in_patients_with_advanced_malignancies_and_varying_degrees_of_hepatic_impairment_an_open-label_single-arm_phase_1_study/3895900
Dataset